Introduction {#s1}
============

In clinical practice, gastroendoscopy (GS) procedures are performed by both gastroenterologists (GE) and hepatologists (HT) in many countries. An increased demand for endoscopic procedures has led to the provision of these services without satisfactory quality assessment methods [@pone.0078557-Ko1]. The importance of performing high-quality endoscopic procedures has increased [@pone.0078557-Faigel1], in particular to prevent acquired infections after the procedures [@pone.0078557-Chiu1]--[@pone.0078557-Chiu2]. In GS, endoscopic biopsy (EBx) remains the gold standard for the investigation and documentation of esophageal, gastric and duodenal pathology [@pone.0078557-Nakanishi1]. EBx is subjective performed by an endoscopist, and the level of skill and experience of the endoscopist may affect the quality of the endoscopic service. Reasons for this discrepancy included lack of experience practitioners to order EBx when required of GS issues between in GE and HT are limited access. Ideally, services should be safe and of high quality. An interesting point of view that focus on the attempt of EBx was investigated the difference between the GE and HT. We proposed this study to try to draw up a guideline along with the endoscopic quality assurance for the adoption of this practice that EBx/GS ratio to be an index for the clinical investigation.

Methods {#s2}
=======

According to the database of computerized records from the endoscopic unit of Kaohsiung Chang Gung Memorial Hospital from January 1998 to June 2012, 215,046 gastroendoscopic procedures (including 864 esophagoscopies, 650 naso-gastroscopies and 213,532 gastroscopies) were performed by 27 attending physicians. According to the Digestive Endoscopy Society of Taiwan, all GE and HT are permitted to perform endoscopic services after completing two years of fellowship training in a hepato-gastroenterology program. In our endoscopic unit, GE/HT were defined as those who own more than 50% documents of gastroenterological/hepatological related publications in Pub Med, respectively. The digestive physicians with 10 years or more experience and/or had credit above associated professor were defined as senior attending physicians. The digestive physicians with less than 10 years of experience were defined as junior attending physicians. One physician retired and one left during the study period, and therefore 25 physicians were enrolled in this study (13 GE: 9 senior and 4 junior; 12 HT: 9 senior and 3 junior). In total, 34,570 episodes of EBx and 199,877 GS were analyzed. Because the junior physicians did not have 10 years of experience, 1-year (short-term) and 5-year (mid-term) investigations were used in the statistical analysis. The indications for upper endoscopies for the GE and HT are shown in [Table 1](#pone-0078557-t001){ref-type="table"}. Because there could be more than one indication, the number of indications was higher than the number of patients. No severe complications after the endoscopic biopsies such as bleeding, perforations and infections were noted. A small amount of bleeding is inevitable after an endoscopic biopsy, and all cases stopped spontaneously or by endoscopic hemostasis.

10.1371/journal.pone.0078557.t001

###### Indications for upper endoscopies for the gastroenterologists and hepatologists.

![](pone.0078557.t001){#pone-0078557-t001-1}

  Indications for endoscopy[\*](#nt101){ref-type="table-fn"}           GE (%)              HT (%)         *P* value     
  ------------------------------------------------------------ ---------------------- ---------------- ---------------- ----------
  UGI bleeding                                                                           2597 (1.1)       911 (0.9)      \<0.0001
  PU                                                                                     149 (0.1)        142 (0.1)         0
  Esophagus                                                             GERD             7716 (3.4)       5037 (4.9)     \<0.0001
                                                                       Ulcer             4786 (2.1)       2348 (2.3)     \<0.0001
                                                                       Cancer            2584 (1.1)       525 (0.5)      \<0.0001
                                                                       Polyp             1016 (0.4)       278 (0.3)      \<0.0001
                                                                  Submucosa tumor        1421 (0.6)       258 (0.3)      \<0.0001
                                                                      Varices           10523 (4.6)       6686 (6.6)     \<0.0001
                                                                   Mallory Weiss         188 (0.1)         12 (0.0)      \<0.0001
                                                                 Hiatus herniation       5907 (2.6)       1488 (1.5)        0
                                                                     Achalasia           403 (0.2)         30 (0.0)      \<0.0001
                                                                      Barrett            991 (0.4)        158 (0.2)      \<0.0001
                                                                       Other             5933 (2.6)       488 (0.5)         0
  Stomach                                                            Gastritis          57055 (24.9)     21822 (21.4)       0
                                                                      Erosion           24982 (10.9)     17613 (17.3)    \<0.0001
                                                                       Ulcer            30477 (13.3)     14571 (14.3)       0
                                                                       Cancer            1610 (0.7)       708 (0.7)      \<0.0001
                                                                       Polyp             6441 (2.8)       3041 (3.0)     \<0.0001
                                                                  Submucosa tumor        4719 (2.1)       1021 (1.0)        0
                                                                      Lymphoma           312 (0.1)         64 (0.1)      \<0.0001
                                                                 Chronic Gastritis       9230 (4.0)       1316 (1.3)        0
                                                                      Varices            3354 (1.5)       2093 (2.1)     \<0.0001
                                                                   Angiodysplasia        933 (0.4)        292 (0.3)      \<0.0001
                                                                      Xanthoma           2058 (0.9)       927 (0.9)      \<0.0001
                                                                   Marginal ulcer        836 (0.4)        420 (0.4)      \<0.0001
                                                                  Stomal gastritis       1246 (0.5)       880 (0.9)      \<0.0001
                                                                        PHG              976 (0.4)        1462 (1.4)     \<0.0001
                                                                Endoscopic treatment     2002 (0.9)       909 (0.9)      \<0.0001
                                                                        EVL              1295 (0.6)       909 (0.9)      \<0.0001
                                                                       Other             5068 (2.2)       1534 (1.5)        0
  Duodenum                                                             Ulcer            19356 (8.5)       9813 (9.6)        0
                                                                Endoscopic treatment     287 (0.1)         80 (0.1)      \<0.0001
                                                                      Lymphoma           312 (0.1)         64 (0.1)      \<0.0001
                                                                Endoscopic treatment    12129 (5.3)       3911 (3.8)        0
  **Total**                                                                            228892 (100.0)   101811 (100.0)  

Indications can be more than one selection for each case.

PHG: portal hypertensive gastropathy; PU: peptic ulcer; UGI: upper gastrointestine; EVL: esophageal varices ligation; GE gastroenterologist; GERD; gastroesophageal reflux disease; HT: hepatologist.

Ethics Statement {#s2a}
----------------

All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki. Written informed consent was obtained from all participants for their information to be stored in the hospital database and used for research. This study was approved by the Institutional Review Board of Chang Gung Memorial Hospital Ethics Committee (No.102-2299B).

Statistical Analysis {#s2b}
--------------------

All statistical analyses were performed using the Trimmean method of Microsoft Office Excel 2007 with percent = 0.2. A mean trimmed 20% was computed by discarding the lower and higher 10% of the scores and taking the mean of the remaining scores (<http://www.java2s.com/Tutorial/Microsoft-Office-Excel-2007/0420__Statistical-functions/TRIMMEANarraypercentreturnsthemeanoftheinteriorofadataset.htm>), and Pearson correlation coefficient analysis was performed (<http://www.java2s.com/Tutorial/Microsoft-Office-Excel-2007/0420__Statistical-functions/PEARSONindependentdependentreturnsthePearsonproductmomentcorrelationcoefficient.htm>) to create standard quality assurance curves of EBx/GS linear correlation with 95% mean prediction intervals. Comparisons of parameters of the EBx/GS ratio between 1-year and 5-year investigations of the GE and HT were performed using the *X* ^2^ test, Fisher's exact test, and Student's *t*-test with SPSS software (version 12.0; SPSS, Chicago, IL, USA). *P* values less than 0.05 were considered to be statistically significant.

Results {#s3}
=======

The ratio of EBx/GS was 17.29% (34570/199877, mean biopsy rate 19.87±8.14%) for the 27 endoscopists over the 14.5-year study period. The Pearson correlation coefficient was 0.90229. The Trimmean of EBx/GS was 19.29% (34570/199877 over 14.5 years) with Trimmean 0.2 percentile ratio correlation, R^2^ = 0.8141 (27, 0.2) ([Figure 1](#pone-0078557-g001){ref-type="fig"}) ([Table 2](#pone-0078557-t002){ref-type="table"}). In 1-year and 5-year investigations, the ratio of EBx/GS was significantly higher in the GE group than in the HT group (21.5% vs. 15.1% and 20.9% vs. 17.3%, respectively, P\<0.00001)([Table 2](#pone-0078557-t002){ref-type="table"}). There were no significant differences between the 1-year and 5-year analyses in both the GE and HT groups ([Table 2](#pone-0078557-t002){ref-type="table"}). In the 5-year analysis with the 25 endoscopists, there were significantly more EBx procedures in the GE group than in the HT group (20.9% vs. 17.3%, P\<0.0001) ([Table 3](#pone-0078557-t003){ref-type="table"}). The junior GE attempted significantly more EBx procedures than both the senior GE (24.1% vs. 20.4%, P\<0.0001) and the junior HT (24.1% vs. 13.2%, P\<0.0001) ([Table 3](#pone-0078557-t003){ref-type="table"}). For the HT group, the EBx/GS was significantly higher for the senior than the junior physicians (18.3% vs. 13.2%, P\<0.0001) ([Table 3](#pone-0078557-t003){ref-type="table"}). According to the indications for endoscopy ([Table 1](#pone-0078557-t001){ref-type="table"}), the discrepancies between the GE and HT groups were significantly different, especially in esophageal varices, gastric varices and portal hypertensive gastropathy.

![The ratio of the 34,570 endoscopic biopsies and 199,877 gastroendoscopic services with Trimmean (0.2 percent) correction performed by 27 endoscopists including 15 gastroenterologists and 12 hepatologists over 14.5 years.](pone.0078557.g001){#pone-0078557-g001}

10.1371/journal.pone.0078557.t002

###### The ratio of endoscopic biopsy/gastroendoscopic procedures and Trimmean modified with Trimmean statistical method of Microsoft Office Excel 2007 between the gastroenterologists and hepatologists.

![](pone.0078557.t002){#pone-0078557-t002-2}

  Category                                                                  Gastroenterologist (n = 13)                               Hepatologist (n = 12)                                               
  --------------------------------------------- ------------------------------------------------------------------------------------ ----------------------- ---------- ------- ------ ------- ---------- -------
  1 year                                                                                2261                                                  10503           21.5^a^    22.23   775    5149    15.1^a^    16.50
  5 years                                                                              11185                                                  53492           20.9%^b^   22.36   4446   25679   17.3%^b^   16.97
  14.5 years[\*](#nt104){ref-type="table-fn"}    EBx/GS = 34570/199877, (ratio = 17.29%), (mean = 19.87±8.14%), (Trimmean = 19.29%)                                                                       

Statistic analysis used with Trimmean method of Microsoft Office Excel 2007 with percent = 0.2. A mean trimmed 20% was computed by discarding the lowest and highest 10% of the scores and taking the mean of the remaining scores.

total 27 endoscopists included 15 gastroenterologists and 12 hepatologists; The Pearson correlation coefficient was 0.90229; EBx = endoscopic biopsy; GS = gastroendoscopy;

P\<0.0001.

10.1371/journal.pone.0078557.t003

###### The 5-year endoscopic biopsy/gastroendoscopy ratio of the 25 endoscopists including 13 gastroenterologists and 12 hepatologists and the distribution of senior and junior physicians in our unit.
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                      Gastroenterologist           Hepatologist                      
  ------------- ---- -------------------- ------- -------------- ---- ------ ------- -------------
  Senior         1           1077          2416        44.6       1    579    2060       28.1
                 2           1530          5334        28.7       2    401    1712       23.4
                 3           711           2848        25.0       3    406    1791       22.7
                 4           965           4140        23.3       4    778    4043       19.2
                 5           1170          6120        19.1       5    595    3304       18.0
                 6           1318          7452        17.7       6    216    1344       16.1
                 7           886           5613        15.8       7    212    1377       15.4
                 8           792           5415        14.6       8    415    2859       14.5
                 9           973           6825        14.3       9    199    2303        8.6
  Junior         10          199            612        32.5       10   253    1600       15.8
                 11          717           3017        23.8       11   168    1234       13.6
                 12          712           3101        23.0       12   224    2052       10.9
                 13          135            599        22.5                          
  Total                     11185          53492     20.9^a^           4446   25679     17.3^a^
  All seniors                9422          46163   20.4^b,\ d^         3801   20793   18.3^b,\ e^
  All juniors                1763          7329    24.1^c,\ d^         645    4886    13.2^c,\ e^

EBx: endoscopic biopsy; GS: gastroendoscopy;

*P*\<0.0001.

Discussion {#s4}
==========

Kaohsiung Chang Gung Memorial Hospital is a medical center with 2,715 beds and over 6,900 outpatients and 370 emergency patients. To deliver a high quality medical service, the Hospital adopts a patient-centered approach, safety practices, and encourages innovations in teaching, research and medical services. In this large academic medical cohort study, the average biopsy rate was 17.3% of about 200 thousand endoscopic procedures over a 14.5-year period. Because of differences in EBx for each endoscopist, an appropriate statistical method was used to represent the accuracy, and showed a statistical average of the EBx/GS of 19.87±8.24% with a confidence correlation coefficient of 0.90229. According to the Pearson correlation coefficient, the rate of EBx was statistically related to the GS service. For draw up a standard assurance in endoscopic procedural practice, Trimmean modified with Trimmean statistical method was used to discard the variant data for some endoscopists. A recent study showed that more attending physicians (42%) than fellows (40%) felt that writing a manuscript and belonging to a gastrointestinal society improved knowledge, however the fellows expressed that they needed more practice [@pone.0078557-Koczka1]. In the current study, the higher biopsy ratio for the junior GE (24%) than the senior GE showed that pathological findings can improve experience. That is, the junior GE needed more pathological diagnoses to contribute to the endoscopic findings. In contrast, the lower biopsy ratio for the junior HT (13.2%) than the senior HT (18.3%) suggests a lack of subjective clinical alertness to perform a biopsy, and that the clinical experience of senior HT in interpreting endoscopic findings may not be sufficient. With regards to the indications for the endoscopic procedures, the causes were similar in the two groups. It should be noted that the hepatologists may have been looking for varices and therefore less likely to be taking biopsies in patients with dyspepsia. The large variation in EBx/GS ranging from 8.64% to 44.58% makes it difficult to calculate a confident mean. A mean trimmed by 20% is computed by discarding the lower and higher 10% of the scores and taking the mean of the remaining scores. The Trimmean (27, 0.2) of this study was 19.29%, and the R^2^ value was 0.8141, showing that a 19.3% EBx rate was a quality assurance reference for daily clinical GS services. This is a simple method to calculate a reference mean from a large endoscopic unit for endoscopic assurance of quality. There was no evidence to suggest that a higher EBx/GS mean (44.58%) from the senior GE contributed to better results for the early detection of cancer than the HT or junior GE. If there is no apparent reason for this discrepancy, it is a so-called aberration of waste medical resources. Stand on the physician education that it may be an evidence of the deviant behavior with medical waste. Educating physicians is an essential step in establishing a broader culture of compliance and improved integrity in a healthcare system, extending beyond Medicare and Medicaid [@pone.0078557-Agrawal1]--[@pone.0078557-Lakbala1]. Therefore, this behavior needs to be corrected [@pone.0078557-Moriates1]. In contrast, a lower EBx/GS mean down to 8.64%, the endoscopic unit staff should have in charge to make a sense or alarm to correct or review the malpractice for the patient safely in a large academic teaching hospital because of the risky for missing diagnosis. How to measure the assurance of the endoscopic service is very important [@pone.0078557-Challand1]--[@pone.0078557-Rex1]. Therefore, the value of the present study is in suggesting the mean EBx/GS as a guideline to cover both GE and HT in the clinical endoscopic service. We also attempted to calculate an acceptable range in 95% mean prediction interval with ±5% distribution for the clinical reference as a standard quality assurance curve. The R^2^ was equal to 0.43 ([Figure 2](#pone-0078557-g002){ref-type="fig"}). Our results suggest that a ratio of EBx/GS of 19.3±5% (range 14.3% to 24.3%) should be followed by not only GE but also HT in the quality investigation of endoscopic services. There was no significant difference in mean EBx/GS between the 1-year and 5-year observations. Annual performance evaluations should take advantage of this method objectively to observe the physician's medical performance. This emphasizes the importance of focusing service improvement on enhancing the quality of a patient's experience of endoscopy and describes the processes used here for quality assurance of endoscopy units [@pone.0078557-Fried1]. In Taiwan, both GE and HT endoscopists are board certified in gastroenterology. According to the rules of the Digestive Endoscopy Society of Taiwan, all GE and HT are permitted to perform endoscopic service clinically after completing two years of fellowship training in a hepato-gastroenterology program followed by active endoscopic practice and certification from the Digestive Endoscopy Society of Taiwan. There were no definitions for senior or junior certification and no clear definitions to clarify the seniors who were certified in advanced endoscopic techniques. In addition, there were no differences in the endoscopic training and certification between HT and GE. It should be emphasized that biopsy attempts were dependent on the endoscopist. Too many biopsies are a waste of medical resources, and too few biopsies risk misdiagnosis. Therefore, an average curve for clinical reference for each endoscopist may be useful. Bias was present in this study in that misdiagnoses such as discrepancies between macroscopic and microscopic pathological findings was clinical evidence. However, the final diagnosis depended on the pathology. It is very difficult to clarify the misdiagnoses because the endoscopist did not perform a biopsy in each case. Finally, the patient's satisfaction post-investigation is an important part of the endoscopic service [@pone.0078557-Johanson1], and this will be investigated in future studies. Although it is really difficult (if not impossible) to draw a conclusion only from the EBx/GS ration on the endoscopic quality, it may be one of the usable method to educate by positive measures or open to criticism the assurance of the endoscopic service. In contrast, the data regarding complication after biopsy some like bleeding, perforations, and infections that it is a statement of a negative list approach to medical negligence, it does not focus of this thesis statement nor the endoscopists would like to have. One thing would like to emphasize here, a miss-diagnosis should happen when the lesion needs to be biopsy for pathological confirmation but the endoscopist could not do so. The patients-satisfaction post-investigational also a useful index for the endoscopic service but it is a subjective investigation with questionnaire study because of recall bias [@pone.0078557-Ko1] when compared with the EBx/GS ration.

![The 5-year ratio of endoscopic biopsies and gastroendoscopic services with 95% mean prediction interval to create a standard quality assurance curve with ±5% border distribution.](pone.0078557.g002){#pone-0078557-g002}

In conclusion, quality assurance for gastrointestinal endoscopy involves numerous aspects of unit management and patient safety. Quality measures used with the EBx/GS ratio may be one of the best ways to ensure the quality of endoscopic procedures in a teaching hospital. The acceptable mean of EBx/GS was 19.3% ranging from 14.3% to 24.3% in 1-year evaluations.
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